By Connor Hart
Affinity Bancshares will terminate a deal under which it would have been acquired by Atlanta Postal Credit Union. The companies said their boards agreed to call off the deal following discussion between the credit union and regulatory agencies. The all-cash acquisition offer was first made in May. Shares fall 17%, to $18.09, in after-hours trading.
Sangamo Therapeutics will end its gene therapy deal with Pfizer. The biotechnology company said its agreement with the pharmaceutical company on gene therapy for hemophilia A will end effective April 21, 2025. Pfizer said it no longer plans to submit the treatment for approval or try to sell it, according to Sangamo. Shares plummet 54%, to $1.08, in postmarket trading.
CompoSecure will spin off Resolute Holdings Management, a move which will see the investment team at CompoSecure and its associated costs move to Resolute. CompoSecure Executive Chairman David Cote will serve as Resolute's executive chairman, while CompoSecure director Tom Knott will become CEO. Resolute is expected to trade on the Nasdaq under the ticker RHLD, and is expected to have limited profitability in fiscal year 2025, according to CompoSecure. Shares rise 8%, to $16.92, in after-hours trading.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
December 30, 2024 18:27 ET (23:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。